Neck masses differential diagnosis: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Line 245: Line 245:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
| rowspan="21" |Inflammatory
| rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inflammatory
! colspan="2" align="center" style="background:#DCDCDC;" |Acute sialadenitis
! colspan="2" align="center" style="background:#DCDCDC;" |Acute sialadenitis
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Chronic sialadenitis
! colspan="2" align="center" style="background:#DCDCDC;" |Chronic sialadenitis
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|
| align="center" style="background:#F5F5F5;" |  
|-
|-
! rowspan="4" align="center" style="background:#DCDCDC;" |Reactive viral lymphadenopathy
! rowspan="4" align="center" style="background:#DCDCDC;" |Reactive viral lymphadenopathy
Line 305: Line 305:
|-
|-
! align="center" style="background:#DCDCDC;" |EBV
! align="center" style="background:#DCDCDC;" |EBV
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! align="center" style="background:#DCDCDC;" |HIV
! align="center" style="background:#DCDCDC;" |HIV
Line 343: Line 343:
|-
|-
! align="center" style="background:#DCDCDC;" |Viral URI
! align="center" style="background:#DCDCDC;" |Viral URI
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! rowspan="6" align="center" style="background:#DCDCDC;" |Bacterial lymphadenopathy
! rowspan="6" align="center" style="background:#DCDCDC;" |Bacterial lymphadenopathy
Line 459: Line 459:
|-
|-
! align="center" style="background:#DCDCDC;" |Staphylococcal or streptococcal infection
! align="center" style="background:#DCDCDC;" |Staphylococcal or streptococcal infection
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! align="center" style="background:#DCDCDC;" |'''Parasitic lymphadenopathy'''
! align="center" style="background:#DCDCDC;" |Parasitic lymphadenopathy
! align="center" style="background:#DCDCDC;" |Toxoplasma gondii
! align="center" style="background:#DCDCDC;" |Toxoplasma gondii
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 517: Line 517:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Amyloidosis
! colspan="2" align="center" style="background:#DCDCDC;" |Amyloidosis
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Sjögren syndrome
! colspan="2" align="center" style="background:#DCDCDC;" |Sjögren syndrome
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Castleman disease (angiofollicular lymphoproliferative disease)
! colspan="2" align="center" style="background:#DCDCDC;" |Castleman disease (angiofollicular lymphoproliferative disease)
Line 574: Line 574:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Kikuchi disease (histiocytic necrotizing lymphadenitis)
! colspan="2" align="center" style="background:#DCDCDC;" |Kikuchi disease (histiocytic necrotizing lymphadenitis)
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Kimura disease
! colspan="2" align="center" style="background:#DCDCDC;" |Kimura disease
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease
! colspan="2" align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease
Line 689: Line 689:
| align="center" style="background:#F5F5F5;" |  
| align="center" style="background:#F5F5F5;" |  
|-
|-
! rowspan="10" align="center" style="background:#DCDCDC;" |'''Salivary gland neoplasm'''
! rowspan="10" align="center" style="background:#DCDCDC;" |Salivary gland neoplasm
! align="center" style="background:#DCDCDC;" |Pleomorphic adenoma
! align="center" style="background:#DCDCDC;" |Pleomorphic adenoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 881: Line 881:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Parathyroid tumors
! colspan="2" align="center" style="background:#DCDCDC;" |Parathyroid tumors
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Carotid body tumors
! colspan="2" align="center" style="background:#DCDCDC;" |Carotid body tumors
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Paraganglioma
! colspan="2" align="center" style="background:#DCDCDC;" |Paraganglioma
Line 976: Line 976:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Liposarcoma
! colspan="2" align="center" style="background:#DCDCDC;" |Liposarcoma
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Lipoma  
! colspan="2" align="center" style="background:#DCDCDC;" |Lipoma  
Line 1,014: Line 1,014:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Glomus vagale, glomus jugulare tumors
! colspan="2" align="center" style="background:#DCDCDC;" |Glomus vagale, glomus jugulare tumors
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Metastatic head and neck carcinoma
! colspan="2" align="center" style="background:#DCDCDC;" |Metastatic head and neck carcinoma
Line 1,053: Line 1,053:
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! colspan="2" align="center" style="background:#DCDCDC;" |Hematoma
! colspan="2" align="center" style="background:#DCDCDC;" |Hematoma
!
| align="center" style="background:#F5F5F5;" |
* Trauma
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Arteriovenous fistula
! colspan="2" align="center" style="background:#DCDCDC;" |Arteriovenous fistula
!
| align="center" style="background:#F5F5F5;" |
* Trauma with shearing forces
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Goiter
! colspan="2" align="center" style="background:#DCDCDC;" |Goiter
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
!
| align="center" style="background:#F5F5F5;" |
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category

Revision as of 18:07, 14 January 2019

Neck masses Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neck Masses from other Conditions

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neck masses differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Neck masses differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neck masses differential diagnosis

CDC on Neck masses differential diagnosis

Neck masses differential diagnosis in the news

Blogs on Neck masses differential diagnosis

Directions to Hospitals Treating Neck masses

Risk calculators and risk factors for Neck masses differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating neck masses from other Diseases

Differential diagnosis of neck masses include:

Category Diseases Etiology Benign Malignant Clinical manifestation Paraclinical findings Gold standard diagnosis Associated findings
Demography History Symptoms Signs Lab findings Histopathology Imaging
Mass Pain Dysphagia Mass exam Skin changes LAP Others
Congenital Branchial cleft cyst
Thyroglossal duct cyst
Hemangioma
Vascular malformations
Lymphatic malformations
Laryngocele
Ranula
Teratoma
Dermoid cyst
Thymic cyst
Category Diseases Etiology Benign Malignant Demography History Mass Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Inflammatory Acute sialadenitis
Chronic sialadenitis
Reactive viral lymphadenopathy CMV
EBV
HIV
Viral URI
Bacterial lymphadenopathy Tularemia
Brucellosis
Cat-scratch disease
  • Bartonella henselae infection
Actinomycosis
Mycobacterial infections
Staphylococcal or streptococcal infection
Parasitic lymphadenopathy Toxoplasma gondii
Sarcoidosis
Amyloidosis
Sjögren syndrome
Castleman disease (angiofollicular lymphoproliferative disease)
Kikuchi disease (histiocytic necrotizing lymphadenitis)
Kimura disease
Rosai-Dorfman disease
Kawasaki disease
Category Diseases Etiology Benign Malignant Demography History Mass Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Neoplasm Primary thyroid tumor
Salivary gland neoplasm Pleomorphic adenoma +
Warthin's tumor +
Lymphoepithelioma +
Oncocytoma
Monomorphic adenoma
Mucoepidermoid carcinoma
Adenoid cystic carcinoma
Adenocarcinoma
Salivary duct carcinoma
Squamous cell carcinoma
Parathyroid tumors
Carotid body tumors
Paraganglioma
Schwannoma
Lymphoma
Liposarcoma
Lipoma
Glomus vagale, glomus jugulare tumors
Metastatic head and neck carcinoma
Other Hematoma
Arteriovenous fistula
Goiter
Category Diseases Etiology Benign Malignant Demography History Mass Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings

References

Retrieved from "https://www.wikidoc.org/index.php?title=Neck_masses_differential_diagnosis&oldid=1535605"